1. Home
  2. HCWB

HCWB

HCW Biologics Inc.

Logo HCW Biologics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

Founded: 2018 Country:
United States
United States
Employees: N/A City: MIRAMAR
Market Cap: 60.6M IPO Year: 2021
Target Price: $9.00 AVG Volume (30 days): 15.8K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.70 EPS Growth: N/A
52 Week Low/High: $0.91 - $2.32 Next Earning Date: 05-07-2024
Revenue: $560,360 Revenue Growth: -78.33%
Revenue Growth (this year): 136.63% Revenue Growth (next year): -38.46%

Share on Social Networks: